Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby A Eyre

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Cancers|May 13, 2023
The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future PerspectivesToby A Eyre, John C Riches
European Journal of Haematology|July 24, 2022
Venetoclax induces deep and durable minimal residual disease-negative remission in high-risk TP53 disrupted B prolymphocytic leukaemiaLucia Y Chen, Toby A Eyre
Hematological Oncology|October 29, 2021
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia managementToby A Eyre, Satoshi Hori, Talha Munir
Blood Advances|March 24, 2025
Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic reviewAisling Barrett, Callum Harris, Toby A Eyre
British Journal of Haematology|March 13, 2021
The use of frailty assessments in treating older adults with aggressive lymphomasRaul Cordoba, Stefano Luminari, Toby A Eyre
Hematology/Oncology Clinics of North America|August 31, 2020
What Causes Bruton Tyrosine Kinase Inhibitor Resistance in Mantle Cell Lymphoma and How Should We Treat Such Patients?Rory McCulloch, Toby A Eyre, Simon Rule
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2022
Emerging Therapies for the Management of Richter TransformationElizabeth Smyth, Toby A Eyre, Chan Y Cheah
Current Hematologic Malignancy Reports|June 30, 2019
Front-Line Treatment of High Grade B Cell Non-Hodgkin LymphomaMurali Kesavan, Toby A Eyre, Graham P Collins
Blood|October 22, 2021
Therapeutic options for relapsed/refractory mantle cell lymphomaToby A Eyre, Chan Y Cheah, Michael L Wang
British Journal of Haematology|April 23, 2014
Dutcher bodies: cytoplasmic inclusions within the nucleusToby A Eyre, Tim J Littlewood, Barbara J Bain
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Cancers|May 13, 2023
The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future PerspectivesToby A Eyre, John C Riches
European Journal of Haematology|July 24, 2022
Venetoclax induces deep and durable minimal residual disease-negative remission in high-risk TP53 disrupted B prolymphocytic leukaemiaLucia Y Chen, Toby A Eyre
Hematological Oncology|October 29, 2021
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia managementToby A Eyre, Satoshi Hori, Talha Munir
Blood Advances|March 24, 2025
Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic reviewAisling Barrett, Callum Harris, Toby A Eyre
British Journal of Haematology|March 13, 2021
The use of frailty assessments in treating older adults with aggressive lymphomasRaul Cordoba, Stefano Luminari, Toby A Eyre
Hematology/Oncology Clinics of North America|August 31, 2020
What Causes Bruton Tyrosine Kinase Inhibitor Resistance in Mantle Cell Lymphoma and How Should We Treat Such Patients?Rory McCulloch, Toby A Eyre, Simon Rule
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2022
Emerging Therapies for the Management of Richter TransformationElizabeth Smyth, Toby A Eyre, Chan Y Cheah
Current Hematologic Malignancy Reports|June 30, 2019
Front-Line Treatment of High Grade B Cell Non-Hodgkin LymphomaMurali Kesavan, Toby A Eyre, Graham P Collins
Blood|October 22, 2021
Therapeutic options for relapsed/refractory mantle cell lymphomaToby A Eyre, Chan Y Cheah, Michael L Wang
British Journal of Haematology|April 23, 2014
Dutcher bodies: cytoplasmic inclusions within the nucleusToby A Eyre, Tim J Littlewood, Barbara J Bain
Pageof 16